# ANTHEM share price, delivery % and history — Anthem Biosciences Limited

> Delivery percentage for Anthem Biosciences Limited (ANTHEM) against its own history, with 297 sessions of split-adjusted NSE data from 2025 — plus moving averages, RSI and the 52-week range.

Canonical: https://patternsradar.com/s/ANTHEM

NSE · equity · [Healthcare](https://patternsradar.com/stocks/sector/healthcare.md) · [Pharmaceuticals & Biotechnology](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md)

## Latest session

- Close: 858.6 INR (-1.28% on the day), 2026-09-30
- Delivery: 54.01% of volume taken to demat (20-day average 54.76%)
- Volume: 1.90L shares, turnover ₹16.3Cr
- Relative volume: 0.21× of its own 20-day average

## Technicals

- RSI(14): 40.15
- ATR(14): 28.32
- SMA 50: 876.56, SMA 200: 748.45
- 52-week range: 579.15 – 977.55 (-12.17% from the high)

## Performance

- 1 week -2.64%, 1 month -3.86%, 3 months 11.17%
- 6 months 26%, 1 year 4.47%

## Delivery percentage

- Latest: 54.01% (2026-09-30)
- 20-day average: 54.76%
- 1-year average: 54.46%
- Percentile against its own history: 61th
- Range: 18.02% – 89.1% across 297 sessions with a reading

Over the last 20 sessions ANTHEM settled 54.8% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 54.5%. The latest session ranks higher than 61% of the 297 sessions on record for it.

[What delivery percentage measures](https://patternsradar.com/learn/delivery-percentage.md). [Scan the whole market on delivery](https://patternsradar.com/scans/delivery.md).

## Fundamentals

- Market cap: 48,384.5 crore
- P/E (TTM): 84.01 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 10.22 INR, split-adjusted to match the price series
- Revenue growth: -22.58% YoY, -31.55% QoQ
- Profit growth: -11.67% YoY, -36.79% QoQ

## Quarterly results

Last 5 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2025-06-30 | 540.2 | 376.8 | 186.2 | 135.8 | 2.43 | 25.14% |
| 2025-09-30 | 550 | 368.7 | 229.6 | 173.4 | 3.09 | 31.53% |
| 2025-12-31 | 423.2 | 300.8 | 130.5 | 92.8 | 1.65 | 21.93% |
| 2026-03-31 | 610.9 | 385.2 | 277.9 | 189.8 | 3.38 | 31.06% |
| 2026-06-30 | 418.2 | 298.5 | 144.6 | 119.9 | 2.13 | 28.68% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 71.42%
- Public: 28.58%
- FII: 2.58%, DII: 13.48%
- Promoter shares pledged: 0%

## Recent filings

- 2026-07-21: results for 2026-06-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_176481_21072026170610_iXBRL_WEB.html
- 2026-07-17: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1695787_17072026084356_WEB.xml
- 2026-06-25: dividend
- 2026-05-20: results for 2026-03-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_159131_20052026001220_iXBRL_WEB.html
- 2026-04-20: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1655577_20042026075836_WEB.xml
- 2026-02-05: results for 2025-12-31 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_140623_05022026192714_iXBRL_WEB.html
- 2026-01-16: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1602285_16012026035550_WEB.xml
- 2025-11-09: results for 2025-09-30 both — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_125470_09112025124133_iXBRL_WEB.html

Dated by the day the company broadcast the filing. 11 events are indexed for this instrument.

## About the instrument

- Listed: 2025-07-21 — latest session 2026-09-30 (297 sessions)
- ISIN: INE0CZ201020
- Series: EQ
- Liquidity rank: #339 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

## More in Pharmaceuticals & Biotechnology

- [DIVISLAB](https://patternsradar.com/s/DIVISLAB.md) — Divi's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [LAURUSLABS](https://patternsradar.com/s/LAURUSLABS.md) — Laurus Labs Limited (Pharmaceuticals & Biotechnology)
- [WOCKPHARMA](https://patternsradar.com/s/WOCKPHARMA.md) — Wockhardt Limited (Pharmaceuticals & Biotechnology)
- [SUNPHARMA](https://patternsradar.com/s/SUNPHARMA.md) — Sun Pharmaceutical Industries Limited (Pharmaceuticals & Biotechnology)
- [MOREPENLAB](https://patternsradar.com/s/MOREPENLAB.md) — Morepen Laboratories Limited (Pharmaceuticals & Biotechnology)
- [DRREDDY](https://patternsradar.com/s/DRREDDY.md) — Dr. Reddy's Laboratories Limited (Pharmaceuticals & Biotechnology)
- [SYMBIOTEC](https://patternsradar.com/s/SYMBIOTEC.md) — SYMBIOTEC (Pharmaceuticals & Biotechnology)
- [GLAND](https://patternsradar.com/s/GLAND.md) — Gland Pharma Limited (Pharmaceuticals & Biotechnology)
- [ZYDUSLIFE](https://patternsradar.com/s/ZYDUSLIFE.md) — Zydus Lifesciences Limited (Pharmaceuticals & Biotechnology)
- [TORNTPHARM](https://patternsradar.com/s/TORNTPHARM.md) — Torrent Pharmaceuticals Limited (Pharmaceuticals & Biotechnology)
- [LUPIN](https://patternsradar.com/s/LUPIN.md) — Lupin Limited (Pharmaceuticals & Biotechnology)
- [AHCL](https://patternsradar.com/s/AHCL.md) — Anlon Healthcare Limited (Pharmaceuticals & Biotechnology)

[All Pharmaceuticals & Biotechnology stocks on the NSE](https://patternsradar.com/stocks/industry/pharmaceuticals-biotechnology.md) · [All Healthcare stocks on the NSE](https://patternsradar.com/stocks/sector/healthcare.md)

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/ANTHEM.

---

Price and delivery data from the [eod2](https://github.com/BennyThadikaran/eod2) dataset: National Stock Exchange of India end-of-day files, split- and bonus-adjusted, updated after each close. Not affiliated with or endorsed by NSE. PatternsRadar is a research tool. Nothing here is investment advice or a recommendation to buy or sell anything.